Jacques Thibodeau - Publications

Affiliations: 
Microbiology and Immunology Université de Montréal, Montréal, Canada 
Area:
Immunology

65 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Cloutier M, Fortin JS, Thibodeau J. The transmembrane domain and luminal C-terminal region independently support invariant chain trimerization and assembly with MHCII into nonamers. Bmc Immunology. 22: 56. PMID 34384367 DOI: 10.1186/s12865-021-00444-6  0.394
2019 Majdoubi A, Lee JS, Balood M, Sabourin A, DeMontigny A, Kishta OA, Moulefera MA, Galbas T, Yun TJ, Talbot S, Ishido S, Cheong C, Thibodeau J. Downregulation of MHC Class II by Ubiquitination Is Required for the Migration of CD206 Dendritic Cells to Skin-Draining Lymph Nodes. Journal of Immunology (Baltimore, Md. : 1950). PMID 31659013 DOI: 10.4049/Jimmunol.1900593  0.345
2018 Thibodeau J, Moulefera MA, Balthazard R. On the structure-function of MHC class ii molecules and how single amino acid polymorphisms could alter intracellular trafficking. Human Immunology. PMID 30321632 DOI: 10.1016/J.Humimm.2018.10.001  0.563
2018 Letendre C, Auger JP, Lemire P, Galbas T, Gottschalk M, Thibodeau J, Segura M. Serotype 2 Infection Impairs Interleukin-12 Production and the MHC-II-Restricted Antigen Presentation Capacity of Dendritic Cells. Frontiers in Immunology. 9: 1199. PMID 29899744 DOI: 10.3389/Fimmu.2018.01199  0.484
2018 Kishta OA, Sabourin A, Simon L, McGovern T, Raymond M, Galbas T, Majdoubi A, Ishido S, Martin JG, Thibodeau J. March1 E3 Ubiquitin Ligase Modulates Features of Allergic Asthma in an Ovalbumin-Induced Mouse Model of Lung Inflammation. Journal of Immunology Research. 2018: 3823910. PMID 29854835 DOI: 10.1155/2018/3823910  0.329
2017 Lemire P, Galbas T, Thibodeau J, Segura M. Natural Killer Cell Functions during the Innate Immune Response to Pathogenic Streptococci. Frontiers in Microbiology. 8: 1196. PMID 28706510 DOI: 10.3389/Fmicb.2017.01196  0.346
2016 Galbas T, Raymond M, Sabourin A, Bourgeois-Daigneault MC, Guimont-Desrochers F, Yun TJ, Cailhier JF, Ishido S, Lesage S, Cheong C, Thibodeau J. MARCH1 E3 Ubiquitin Ligase Dampens the Innate Inflammatory Response by Modulating Monocyte Functions in Mice. Journal of Immunology (Baltimore, Md. : 1950). PMID 27940660 DOI: 10.4049/Jimmunol.1601168  0.712
2016 Lecours MP, Letendre C, Clarke D, Lemire P, Galbas T, Benoit-Biancamano MO, Thibodeau J, Gottschalk M, Segura M. Immune-responsiveness of CD4(+) T cells during Streptococcus suis serotype 2 infection. Scientific Reports. 6: 38061. PMID 27905502 DOI: 10.1038/Srep38061  0.343
2016 Nagarajan A, Petersen MC, Nasiri AR, Butrico G, Fung A, Ruan HB, Kursawe R, Caprio S, Thibodeau J, Bourgeois-Daigneault MC, Sun L, Gao G, Bhanot S, Jurczak MJ, Green MR, et al. MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels. Nature Communications. 7: 12639. PMID 27577745 DOI: 10.1038/Ncomms12639  0.658
2016 Clarke D, Letendre C, Lecours MP, Lemire P, Galbas T, Thibodeau J, Segura M. Group B Streptococcus Induces a Robust IFN-γ Response by CD4(+) T Cells in an In Vitro and In Vivo Model. Journal of Immunology Research. 2016: 5290604. PMID 26989699 DOI: 10.1155/2016/5290604  0.337
2016 Majdoubi A, Kishta OA, Thibodeau J. Role of antigen presentation in the production of pro-inflammatory cytokines in obese adipose tissue. Cytokine. PMID 26854212 DOI: 10.1016/J.Cyto.2016.01.023  0.307
2015 Cloutier M, Gauthier C, Fortin JS, Genève L, Kim K, Gruenheid S, Kim J, Thibodeau J. ER egress of invariant chain isoform p35 requires direct binding to MHCII molecules and is inhibited by the NleA virulence factor of enterohaemorrhagic Escherichia coli. Human Immunology. 76: 292-6. PMID 25731712 DOI: 10.1016/J.Humimm.2015.02.002  0.433
2014 Genève L, Gauthier C, Thibodeau J. The D-6 mouse monoclonal antibody recognizes the CD74 cytoplasmic tail. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 33: 221-7. PMID 25171001 DOI: 10.1089/mab.2013.0078  0.379
2014 Cloutier M, Gauthier C, Fortin JS, Thibodeau J. The invariant chain p35 isoform promotes formation of nonameric complexes with MHC II molecules. Immunology and Cell Biology. 92: 553-6. PMID 24638068 DOI: 10.1038/Icb.2014.17  0.453
2014 Fortin JS, Genève L, Gauthier C, Shoukry NH, Azar GA, Younes S, Yassine-Diab B, Sékaly RP, Fremont DH, Thibodeau J. MMTV superantigens coerce an unconventional topology between the TCR and MHC class II. Journal of Immunology (Baltimore, Md. : 1950). 192: 1896-906. PMID 24453254 DOI: 10.4049/Jimmunol.1203130  0.449
2013 Bourgeois-Daigneault MC, Pezeshki AM, Galbas T, Houde M, Baril M, Früh K, Amrani A, Ishido S, Lamarre D, Thibodeau J. Tollip-induced down-regulation of MARCH1. Results in Immunology. 3: 17-25. PMID 24600555 DOI: 10.1016/J.Rinim.2013.02.002  0.805
2013 Fortin JS, Cloutier M, Thibodeau J. Exposing the Specific Roles of the Invariant Chain Isoforms in Shaping the MHC Class II Peptidome. Frontiers in Immunology. 4: 443. PMID 24379812 DOI: 10.3389/Fimmu.2013.00443  0.515
2013 Pezeshki AM, Azar GA, Mourad W, Routy JP, Boulassel MR, Denzin LK, Thibodeau J. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides. Human Immunology. 74: 1280-7. PMID 23756162 DOI: 10.1016/J.Humimm.2013.05.010  0.568
2013 Bourgeois-Daigneault MC, Thibodeau J. Identification of a novel motif that affects the conformation and activity of the MARCH1 E3 ubiquitin ligase. Journal of Cell Science. 126: 989-98. PMID 23264739 DOI: 10.1242/Jcs.117804  0.743
2013 Finzi A, Perlman M, Bourgeois-Daigneault MC, Thibodeau J, Cohen ÉA. Major histocompatibility complex class-II molecules promote targeting of human immunodeficiency virus type 1 virions in late endosomes by enhancing internalization of nascent particles from the plasma membrane. Cellular Microbiology. 15: 809-22. PMID 23170932 DOI: 10.1111/Cmi.12074  0.734
2012 Thibodeau J, Bourgeois-Daigneault MC, Lapointe R. Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy. Oncoimmunology. 1: 908-916. PMID 23162758 DOI: 10.4161/Onci.21205  0.749
2012 Genève L, Ménard C, Labrecque N, Thibodeau J. The p35 human invariant chain in transgenic mice restores mature B cells in the absence of endogenous CD74. International Immunology. 24: 645-60. PMID 22966065 DOI: 10.1093/Intimm/Dxs066  0.499
2012 Genève L, Chemali M, Desjardins M, Labrecque N, Thibodeau J. Human invariant chain isoform p35 restores thymic selection and antigen presentation in CD74-deficient mice. Immunology and Cell Biology. 90: 896-902. PMID 22689013 DOI: 10.1038/Icb.2012.27  0.489
2012 Bourgeois-Daigneault MC, Thibodeau J. Autoregulation of MARCH1 expression by dimerization and autoubiquitination. Journal of Immunology (Baltimore, Md. : 1950). 188: 4959-70. PMID 22508929 DOI: 10.4049/Jimmunol.1102708  0.743
2012 Galbas T, Steimle V, Lapointe R, Ishido S, Thibodeau J. MARCH1 down-regulation in IL-10-activated B cells increases MHC class II expression. Cytokine. 59: 27-30. PMID 22503116 DOI: 10.1016/J.Cyto.2012.03.015  0.445
2012 Galbas T, Thibodeau J. Cell-type specific regulation of MARCH1 E3 ubiquitin ligase by the anti-inflammatory cytokine IL-10 Open Journal of Immunology. 2: 161-167. DOI: 10.4236/Oji.2012.24020  0.427
2011 Xiu F, Côté MH, Bourgeois-Daigneault MC, Brunet A, Gauvreau MÉ, Shaw A, Thibodeau J. Cutting edge: HLA-DO impairs the incorporation of HLA-DM into exosomes. Journal of Immunology (Baltimore, Md. : 1950). 187: 1547-51. PMID 21768396 DOI: 10.4049/Jimmunol.1100199  0.784
2011 Pezeshki AM, Côté MH, Azar GA, Routy JP, Boulassel MR, Thibodeau J. Forced expression of HLA-DM at the surface of dendritic cells increases loading of synthetic peptides on MHC class II molecules and modulates T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 187: 74-81. PMID 21622867 DOI: 10.4049/Jimmunol.1002747  0.494
2011 Thibodeau J, Bourgeois-Daigneault MC, Lapointe R. Counteracting subversion of MHC class II antigen presentation by tumors Experimental and Applied Immunotherapy. 173-194. DOI: 10.1007/978-1-60761-980-2_8  0.72
2009 Gauvreau ME, Côté MH, Bourgeois-Daigneault MC, Rivard LD, Xiu F, Brunet A, Shaw A, Steimle V, Thibodeau J. Sorting of MHC class II molecules into exosomes through a ubiquitin-independent pathway. Traffic (Copenhagen, Denmark). 10: 1518-27. PMID 19566897 DOI: 10.1111/J.1600-0854.2009.00948.X  0.801
2009 Deshaies F, Diallo DA, Fortin JS, O'Rourke HM, Pezeshki AM, Bellemare-Pelletier A, Raby N, Bédard N, Brunet A, Denzin LK, Thibodeau J. Evidence for a human leucocyte antigen-DM-induced structural change in human leucocyte antigen-DOβ Immunology. 127: 408-417. PMID 19019088 DOI: 10.1111/J.1365-2567.2008.02984.X  0.812
2008 Thibodeau J, Bourgeois-Daigneault MC, Huppé G, Tremblay J, Aumont A, Houde M, Bartee E, Brunet A, Gauvreau ME, de Gassart A, Gatti E, Baril M, Cloutier M, Bontron S, Früh K, et al. Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. European Journal of Immunology. 38: 1225-30. PMID 18389477 DOI: 10.1002/Eji.200737902  0.77
2008 De Gassart A, Camosseto V, Thibodeau J, Ceppi M, Catalan N, Pierre P, Gatti E. MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proceedings of the National Academy of Sciences of the United States of America. 105: 3491-6. PMID 18305173 DOI: 10.1073/Pnas.0708874105  0.534
2008 Bourgeois-Daigneault M, Huppé G, Tremblay J, Steimle V, Thibodeau J. 144 Molecular mechanisms of MHC class II inhibition by the MARCH1 ubiquitin ligase in response to IL-10 Cytokine. 43: 269. DOI: 10.1016/J.Cyto.2008.07.186  0.743
2006 Finzi A, Brunet A, Xiao Y, Thibodeau J, Cohen EA. Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments. Journal of Virology. 80: 9789-97. PMID 16973583 DOI: 10.1128/Jvi.01055-06  0.569
2005 Deshaies F, Thibodeau J. [HLA-DO: regulator of the immune response]. MéDecine Sciences : M/S. 21: 911-2. PMID 16274638 DOI: 10.1051/Medsci/20052111911  0.768
2005 Khalil H, Brunet A, Thibodeau J. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35. Journal of Cell Science. 118: 4679-87. PMID 16188937 DOI: 10.1242/Jcs.02592  0.709
2005 Azar GA, Sékaly RP, Thibodeau J. A defective viral superantigen-presenting phenotype in HLA-DR transfectants is corrected by CIITA. Journal of Immunology (Baltimore, Md. : 1950). 174: 7548-57. PMID 15944254 DOI: 10.4049/Jimmunol.174.12.7548  0.591
2005 Deshaies F, Brunet A, Diallo DA, Denzin LK, Samaan A, Thibodeau J. A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM. Proceedings of the National Academy of Sciences of the United States of America. 102: 6443-8. PMID 15849268 DOI: 10.1073/Pnas.0500853102  0.792
2005 Martin G, Beauséjour Y, Thibodeau J, Tremblay MJ. Envelope glycoproteins are dispensable for insertion of host HLA-DR molecules within nascent human immunodeficiency virus type 1 particles. Virology. 335: 286-90. PMID 15840527 DOI: 10.1016/J.Virol.2005.02.021  0.378
2005 Bellemare-Pelletier A, Tremblay J, Beaulieu S, Boulassel MR, Routy JP, Massie B, Lapointe R, Thibodeau J. HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing. Journal of Leukocyte Biology. 78: 95-105. PMID 15817706 DOI: 10.1189/Jlb.0105020  0.596
2004 El Fakhry Y, Bouillon M, Léveillé C, Brunet A, Khalil H, Thibodeau J, Mourad W. Delineation of the HLA-DR region and the residues involved in the association with the cytoskeleton. The Journal of Biological Chemistry. 279: 18472-80. PMID 14976194 DOI: 10.1074/Jbc.M401159200  0.715
2003 Khalil H, Brunet A, Saba I, Terra R, Sékaly RP, Thibodeau J. The MHC class II beta chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal. International Immunology. 15: 1249-63. PMID 13679394 DOI: 10.1093/Intimm/Dxg124  0.734
2003 Lapointe R, Bellemare-Pelletier A, Housseau F, Thibodeau J, Hwu P. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Research. 63: 2836-43. PMID 12782589  0.397
2003 Bouillon M, El Fakhry Y, Girouard J, Khalil H, Thibodeau J, Mourad W. Lipid raft-dependent and -independent signaling through HLA-DR molecules. The Journal of Biological Chemistry. 278: 7099-107. PMID 12499388 DOI: 10.1074/Jbc.M211566200  0.714
2002 Khalil H, Deshaies F, Bellemare-Pelletier A, Brunet A, Faubert A, Azar GA, Thibodeau J. Class II transactivator-induced expression of HLA-DO(beta) in HeLa cells. Tissue Antigens. 60: 372-82. PMID 12492813 DOI: 10.1034/J.1399-0039.2002.600504.X  0.801
2002 Azar GA, Thibodeau J. Human endogenous retrovirus IDDMK(1,2)22 and mouse mammary tumor virus superantigens differ in their ability to stimulate murine T cell hybridomas. Immunology Letters. 81: 87-91. PMID 11841850 DOI: 10.1016/S0165-2478(01)00340-6  0.305
2002 Faubert A, Samaan A, Thibodeau J. Functional analysis of tryptophans alpha 62 and beta 120 on HLA-DM. The Journal of Biological Chemistry. 277: 2750-5. PMID 11713260 DOI: 10.1074/Jbc.M110300200  0.584
2001 Lavoie PM, McGrath H, Shoukry NH, Cazenave PA, Sékaly RA, Thibodeau J. Quantitative relationship between MHC class II-superantigen complexes and the balance of T cell activation versus death Journal of Immunology. 166: 7229-7237. PMID 11390471 DOI: 10.4049/Jimmunol.166.12.7229  0.534
2000 Brunet A, Samaan A, Deshaies F, Kindt TJ, Thibodeau J. Functional characterization of a lysosomal sorting motif in the cytoplasmic tail of HLA-DObeta. The Journal of Biological Chemistry. 275: 37062-71. PMID 10964920 DOI: 10.1074/jbc.M005112200  0.831
1999 Lavoie PM, Thibodeau J, Erard F, Sékaly RP. Understanding the mechanism of action of bacterial superantigens from a decade of research Immunological Reviews. 168: 257-269. PMID 10399079 DOI: 10.1111/J.1600-065X.1999.Tb01297.X  0.456
1999 Samaan A, Thibodeau J, Mahana W, Castellino F, Cazenave PA, Kindt TJ. Cellular distribution of a mixed MHC class II heterodimer between DRα and a chimeric DOβ chain International Immunology. 11: 99-111. PMID 10050678 DOI: 10.1093/Intimm/11.1.99  0.6
1998 Thibodeau J, Lavoie PM, Samaan A, Corre JP, Sékaly RP, Cazenave PA. Conserved structural features between HLA-DOβ and -DRβ Molecular Immunology. 35: 885-893. PMID 9839557 DOI: 10.1016/S0161-5890(98)00061-3  0.553
1997 Shoukry NH, Lavoie PM, Thibodeau J, D'Souza S, Sekaly RP. MHC class II-dependent peptide antigen versus superantigen presentation to T cells Human Immunology. 54: 194-201. PMID 9297538 DOI: 10.1016/S0198-8859(97)00074-8  0.537
1997 Lavoie PM, Thibodeau J, Cloutier I, Busch R, Sekaly RP. Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA- DM Proceedings of the National Academy of Sciences of the United States of America. 94: 6892-6897. PMID 9192662 DOI: 10.1073/Pnas.94.13.6892  0.566
1997 Thibodeau J, Dohlsten M, Cloutier I, Lavoie PM, Bjork P, Michel F, Léveillé C, Mourad W, Kalland T, Sékaly RP. Molecular Characterization and Role in T Cell Activation of Staphylococcal Enterotoxin a Binding to the HLA-DR α-Chain Journal of Immunology. 158: 3698-3704. PMID 9103433  0.445
1997 Delcourt M, Thibodeau J, Denis F, Sekaly RP. Paracrine transfer of mouse mammary tumor virus superantigen. The Journal of Experimental Medicine. 185: 471-80. PMID 9053447 DOI: 10.1084/Jem.185.3.471  0.541
1997 De Alba YB, Marche PN, Cazenave PA, Cloutier I, Sekaly RP, Thibodeau J. Vα domain modulates the multiple topologies of mouse T cell receptor vβ20/staphylococcal enterotoxins A and E complexes European Journal of Immunology. 27: 92-99. PMID 9022003 DOI: 10.1002/Eji.1830270114  0.413
1995 Fleury S, Thibodeau J, Croteau G, Labrecque N, Aronson HE, Cantin C, Long EO, Sékaly RP. HLA-DR polymorphism affects the interaction with CD4 Journal of Experimental Medicine. 182: 733-741. PMID 7650480 DOI: 10.1084/Jem.182.3.733  0.451
1995 Mehindate K, Thibodeau J, Dohlsten M, Kalland T, Sékaly RP, Mourad W. Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression Journal of Experimental Medicine. 182: 1573-1577. PMID 7595227 DOI: 10.1084/Jem.182.5.1573  0.403
1994 Thibodeau J, Labrecque N, Denis F, Huber BT, Sékaly RP. Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules Journal of Experimental Medicine. 179: 1029-1034. PMID 8113671 DOI: 10.1084/Jem.179.3.1029  0.535
1994 Thibodeau J, Cloutier I, Lavoie PM, Labrecque N, Mourad W, Jardetzky T, Sékaly RP. Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding Science. 266: 1874-1878. PMID 7997881 DOI: 10.1126/Science.7997881  0.486
1994 Labrecque N, Thibodeau J, Mourad W, Sékaly RP. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens Journal of Experimental Medicine. 180: 1921-1929. PMID 7964467 DOI: 10.1084/Jem.180.5.1921  0.5
1993 Labrecque N, Thibodeau J, Sékaly RP. Interactions between staphylococcal superantigens and MHC class II molecules Seminars in Immunology. 5: 23-32. PMID 8467091 DOI: 10.1006/Smim.1993.1004  0.552
1991 Herman A, Labrecque N, Thibodeau J, Marrack P, Kappler JW, Sekaly RP. Identification of the staphylococcal enterotoxin A superantigen binding site in the β1 domain of the human histocompatibility antigen HLA-DR Proceedings of the National Academy of Sciences of the United States of America. 88: 9954-9958. PMID 1946464 DOI: 10.1073/Pnas.88.22.9954  0.503
Show low-probability matches.